Avadel Pharmaceuticals plc

Historical 13F Holders

Symbol
AVDL
CUSIP
05337M104
All holders as of
Q2 2026
Type
Equity
Class
SPONSORED ADR
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 05337M104 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Jeffrey L. Gendell 13G/A
4.9% 2/6/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q2 1 1.00 $16
2026 Q1 1 1.00 $16
2025 Q4 2 600 k $12.9M
2025 Q3 3 738 k $11.3M
2025 Q2 4 738 k $6.53M
2025 Q1 3 738 k $5.77M
2024 Q4 3 737 k $7.75M
2024 Q3 5 1.07 M $14.0M
2024 Q2 10 7.03 M $98.8M
2024 Q1 125 68.1 M $1.15B
2023 Q4 117 56.3 M $795M
2023 Q3 102 54.4 M $559M
2023 Q2 102 52.0 M $856M
2023 Q1 97 48.4 M $443M
2022 Q4 90 33.5 M $239M
2022 Q3 81 31.4 M $157M
2022 Q2 87 33.7 M $82.4M
2022 Q1 86 35.9 M $252M
2021 Q4 86 34.9 M $282M
2021 Q3 86 32.1 M $314M
2021 Q2 84 32.6 M $219M
2021 Q1 80 32.6 M $294M
2020 Q4 84 32.0 M $214M
2020 Q3 83 31.5 M $159M
2020 Q2 83 36.3 M $293M
2020 Q1 65 26.9 M $211M
2019 Q4 43 18.4 M $139M
2019 Q3 45 19.4 M $80.6M
2019 Q2 46 19.4 M $56.2M
2019 Q1 50 19.6 M $28.2M
2018 Q4 60 19.8 M $51.0M
2018 Q3 66 20.2 M $88.7M
2018 Q2 76 21.2 M $130M
2018 Q1 81 25.9 M $189M
2017 Q4 83 26.4 M $216M
2017 Q3 82 27.2 M $285M
2017 Q2 78 27.8 M $306M
2017 Q1 75 27.9 M $270M
2016 Q4 6 4.30 M $44.7M